

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanocyte differentiation (GO:0030318) | 7.67730226 |
| 2 | pigment cell differentiation (GO:0050931) | 7.66688249 |
| 3 | tyrosine metabolic process (GO:0006570) | 7.18003215 |
| 4 | phenol-containing compound biosynthetic process (GO:0046189) | 6.10677516 |
| 5 | melanosome organization (GO:0032438) | 5.20718817 |
| 6 | pigment granule organization (GO:0048753) | 4.96579086 |
| 7 | melanin biosynthetic process (GO:0042438) | 4.81777183 |
| 8 | neuroepithelial cell differentiation (GO:0060563) | 4.61975479 |
| 9 | endosome to pigment granule transport (GO:0043485) | 4.53927758 |
| 10 | endosome to melanosome transport (GO:0035646) | 4.53927758 |
| 11 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.41934427 |
| 12 | detection of light stimulus involved in visual perception (GO:0050908) | 4.41934427 |
| 13 | melanin metabolic process (GO:0006582) | 4.23620538 |
| 14 | secondary metabolite biosynthetic process (GO:0044550) | 3.99068422 |
| 15 | secondary metabolic process (GO:0019748) | 3.83607617 |
| 16 | actin filament depolymerization (GO:0030042) | 3.83150779 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 3.67777925 |
| 18 | retinal rod cell development (GO:0046548) | 3.66375494 |
| 19 | pigmentation (GO:0043473) | 3.57584243 |
| 20 | cell adhesion mediated by integrin (GO:0033627) | 3.41477568 |
| 21 | sodium ion export (GO:0071436) | 3.38275847 |
| 22 | retinal cone cell development (GO:0046549) | 3.36970240 |
| 23 | regulation of water loss via skin (GO:0033561) | 3.33956695 |
| 24 | neuron remodeling (GO:0016322) | 3.33894018 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30542402 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.30542402 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30542402 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30542402 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30542402 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.30542402 |
| 31 | response to host immune response (GO:0052572) | 3.23775179 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23775179 |
| 33 | macroautophagy (GO:0016236) | 3.20566876 |
| 34 | oocyte development (GO:0048599) | 3.11764886 |
| 35 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.09920332 |
| 36 | Golgi to endosome transport (GO:0006895) | 3.06302346 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05166147 |
| 38 | plasma membrane repair (GO:0001778) | 2.99667096 |
| 39 | pigment biosynthetic process (GO:0046148) | 2.97992531 |
| 40 | response to host (GO:0075136) | 2.97537740 |
| 41 | response to host defenses (GO:0052200) | 2.97537740 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97537740 |
| 43 | establishment of skin barrier (GO:0061436) | 2.94476336 |
| 44 | osteoclast differentiation (GO:0030316) | 2.93281770 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90725355 |
| 46 | chondroitin sulfate catabolic process (GO:0030207) | 2.90393674 |
| 47 | peripheral nervous system development (GO:0007422) | 2.89253558 |
| 48 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.88098906 |
| 49 | lipoprotein transport (GO:0042953) | 2.86680987 |
| 50 | positive regulation of muscle hypertrophy (GO:0014742) | 2.84581980 |
| 51 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.84581980 |
| 52 | acrosome reaction (GO:0007340) | 2.83833740 |
| 53 | semaphorin-plexin signaling pathway (GO:0071526) | 2.82410911 |
| 54 | desmosome organization (GO:0002934) | 2.73409970 |
| 55 | centrosome duplication (GO:0051298) | 2.73292008 |
| 56 | basement membrane organization (GO:0071711) | 2.68816684 |
| 57 | multicellular organism reproduction (GO:0032504) | 2.68347311 |
| 58 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.67756201 |
| 59 | regulation of early endosome to late endosome transport (GO:2000641) | 2.64448325 |
| 60 | proline transport (GO:0015824) | 2.63637761 |
| 61 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.63580519 |
| 62 | actin cytoskeleton reorganization (GO:0031532) | 2.61659179 |
| 63 | eye photoreceptor cell development (GO:0042462) | 2.60663719 |
| 64 | cellular response to reactive nitrogen species (GO:1902170) | 2.59604036 |
| 65 | endocardial cushion development (GO:0003197) | 2.58832316 |
| 66 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.58443786 |
| 67 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.58014994 |
| 68 | axon extension involved in axon guidance (GO:0048846) | 2.58014994 |
| 69 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.57756991 |
| 70 | ketone body metabolic process (GO:1902224) | 2.57374197 |
| 71 | photoreceptor cell development (GO:0042461) | 2.57334414 |
| 72 | wound healing, spreading of epidermal cells (GO:0035313) | 2.57220596 |
| 73 | negative regulation of organelle assembly (GO:1902116) | 2.57009339 |
| 74 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.56627127 |
| 75 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56521302 |
| 76 | mitotic G1/S transition checkpoint (GO:0044819) | 2.55895454 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.54861818 |
| 78 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53229897 |
| 79 | potassium ion homeostasis (GO:0055075) | 2.53028461 |
| 80 | regulation of integrin activation (GO:0033623) | 2.50208554 |
| 81 | positive regulation of p38MAPK cascade (GO:1900745) | 2.49756861 |
| 82 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.49505523 |
| 83 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.48586766 |
| 84 | negative regulation of macroautophagy (GO:0016242) | 2.48208815 |
| 85 | relaxation of cardiac muscle (GO:0055119) | 2.47101983 |
| 86 | phospholipid translocation (GO:0045332) | 2.46560282 |
| 87 | lipid translocation (GO:0034204) | 2.46560282 |
| 88 | intestinal epithelial cell development (GO:0060576) | 2.45372427 |
| 89 | rhodopsin mediated signaling pathway (GO:0016056) | 2.43822175 |
| 90 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.43298512 |
| 91 | Rac protein signal transduction (GO:0016601) | 2.43131692 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42443216 |
| 93 | cellular response to nitric oxide (GO:0071732) | 2.41004554 |
| 94 | phospholipid homeostasis (GO:0055091) | 2.39481814 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.38918331 |
| 96 | membrane protein ectodomain proteolysis (GO:0006509) | 2.37837797 |
| 97 | positive regulation of heat generation (GO:0031652) | 2.37382061 |
| 98 | apoptotic cell clearance (GO:0043277) | 2.37378067 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.37128345 |
| 100 | regulation of protein polyubiquitination (GO:1902914) | 2.36760739 |
| 101 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.36280454 |
| 102 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.35862821 |
| 103 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.35849516 |
| 104 | behavioral response to ethanol (GO:0048149) | 2.35653373 |
| 105 | I-kappaB phosphorylation (GO:0007252) | 2.35186350 |
| 106 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.34794772 |
| 107 | cellular response to ATP (GO:0071318) | 2.34596539 |
| 108 | G1 DNA damage checkpoint (GO:0044783) | 2.33282348 |
| 109 | phenol-containing compound metabolic process (GO:0018958) | 2.33235330 |
| 110 | establishment of protein localization to Golgi (GO:0072600) | 2.33101816 |
| 111 | protein targeting to Golgi (GO:0000042) | 2.32734057 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.32138880 |
| 113 | fibroblast migration (GO:0010761) | 2.32073405 |
| 114 | relaxation of smooth muscle (GO:0044557) | 2.31769956 |
| 115 | sperm motility (GO:0030317) | 2.30987504 |
| 116 | synaptic vesicle endocytosis (GO:0048488) | 2.30259085 |
| 117 | regulation of acrosome reaction (GO:0060046) | 2.27298420 |
| 118 | positive regulation of neuroblast proliferation (GO:0002052) | 2.27191275 |
| 119 | cell communication by electrical coupling (GO:0010644) | 2.26970714 |
| 120 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.26851268 |
| 121 | developmental pigmentation (GO:0048066) | 2.26634609 |
| 122 | regulation of female gonad development (GO:2000194) | 2.26022790 |
| 123 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.25887402 |
| 124 | negative regulation of inclusion body assembly (GO:0090084) | 2.25130949 |
| 125 | vitamin transmembrane transport (GO:0035461) | 2.24705751 |
| 126 | pigment metabolic process (GO:0042440) | 2.24456402 |
| 127 | pigment granule transport (GO:0051904) | 2.23165480 |
| 128 | urinary tract smooth muscle contraction (GO:0014848) | 2.23129192 |
| 129 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.23054938 |
| 130 | natural killer cell mediated immunity (GO:0002228) | 2.23054938 |
| 131 | detection of visible light (GO:0009584) | 2.21678180 |
| 132 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.21454302 |
| 133 | early endosome to late endosome transport (GO:0045022) | 2.20976435 |
| 134 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.20944202 |
| 135 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.20728323 |
| 136 | cardiac conduction (GO:0061337) | 2.20656613 |
| 137 | establishment of pigment granule localization (GO:0051905) | 2.20518486 |
| 138 | melanosome transport (GO:0032402) | 2.20408600 |
| 139 | vesicle transport along microtubule (GO:0047496) | 2.20222002 |
| 140 | endosome organization (GO:0007032) | 2.20032620 |
| 141 | cellular response to ethanol (GO:0071361) | 2.19935273 |
| 142 | dermatan sulfate biosynthetic process (GO:0030208) | 2.19917656 |
| 143 | multicellular organismal water homeostasis (GO:0050891) | 2.19776303 |
| 144 | regulation of alkaline phosphatase activity (GO:0010692) | 2.19762710 |
| 145 | glomerular epithelial cell development (GO:0072310) | 2.19483875 |
| 146 | pigment granule localization (GO:0051875) | 2.18833446 |
| 147 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.18777185 |
| 148 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.18776756 |
| 149 | regulation of mononuclear cell migration (GO:0071675) | 2.18622309 |
| 150 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.18597138 |
| 151 | axonemal dynein complex assembly (GO:0070286) | 2.18538274 |
| 152 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.18299152 |
| 153 | establishment of melanosome localization (GO:0032401) | 2.17766601 |
| 154 | reproduction (GO:0000003) | 2.17623785 |
| 155 | adhesion of symbiont to host cell (GO:0044650) | 2.16819908 |
| 156 | virion attachment to host cell (GO:0019062) | 2.16819908 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.16455976 |
| 158 | melanosome localization (GO:0032400) | 2.16240675 |
| 159 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.16034406 |
| 160 | keratan sulfate catabolic process (GO:0042340) | 2.15665837 |
| 161 | protein localization to endosome (GO:0036010) | 2.15362543 |
| 162 | glial cell migration (GO:0008347) | 2.15110631 |
| 163 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.14715201 |
| 164 | angiogenesis involved in wound healing (GO:0060055) | 2.14701401 |
| 165 | aromatic amino acid family metabolic process (GO:0009072) | 2.14674357 |
| 166 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.14625799 |
| 167 | positive regulation of receptor recycling (GO:0001921) | 2.14625226 |
| 168 | glomerular visceral epithelial cell development (GO:0072015) | 2.12333806 |
| 169 | detection of light stimulus (GO:0009583) | 2.12192716 |
| 170 | smooth muscle tissue development (GO:0048745) | 2.11089080 |
| 171 | calcium ion-dependent exocytosis (GO:0017156) | 2.09941315 |
| 172 | protein-chromophore linkage (GO:0018298) | 2.09860443 |
| 173 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.09835224 |
| 174 | regulation of bile acid biosynthetic process (GO:0070857) | 2.09817887 |
| 175 | enteric nervous system development (GO:0048484) | 2.09556518 |
| 176 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.08472825 |
| 177 | cellular sodium ion homeostasis (GO:0006883) | 2.07729711 |
| 178 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.06855308 |
| 179 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.06855308 |
| 180 | detection of temperature stimulus (GO:0016048) | 2.06754485 |
| 181 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.04588327 |
| 182 | neurofilament cytoskeleton organization (GO:0060052) | 2.03860110 |
| 183 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.03673328 |
| 184 | cellular response to interferon-alpha (GO:0035457) | 2.03646591 |
| 185 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.03447775 |
| 186 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.02179463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.60434613 |
| 2 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45247300 |
| 3 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.39403883 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.36910067 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00885916 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90932816 |
| 7 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90055843 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86822050 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71523192 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70297637 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65323548 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.65107176 |
| 13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.64804774 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64185030 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58696623 |
| 16 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.58047117 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57432153 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56378841 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55472471 |
| 20 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55131573 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 1.51306028 |
| 22 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.50692464 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49449197 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47978809 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47709183 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47373791 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47360913 |
| 28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47300580 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47300580 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41379566 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37777484 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36369254 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36012350 |
| 34 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35063575 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34951812 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34340138 |
| 37 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33922480 |
| 38 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32657910 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27612530 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27078624 |
| 41 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26828812 |
| 42 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.25576651 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22594742 |
| 44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21982518 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19491912 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19036534 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18780340 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18399497 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17990575 |
| 50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17829115 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16428371 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15157905 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15136504 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14886869 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14113335 |
| 56 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13013472 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12981614 |
| 58 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12142118 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12031923 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12031923 |
| 61 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11712137 |
| 62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11524532 |
| 63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11524532 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11121125 |
| 65 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11026562 |
| 66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10968021 |
| 67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10815146 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10723242 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10225865 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10185616 |
| 71 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10158295 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10022522 |
| 73 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.09699580 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09505908 |
| 75 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08979366 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08979366 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08737122 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08112257 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08094412 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08044864 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07213708 |
| 82 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06351750 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06321657 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05895201 |
| 85 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05666774 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05562209 |
| 87 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05426914 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03394370 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03354574 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02585942 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02258766 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02257909 |
| 93 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.01648495 |
| 94 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01553237 |
| 95 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00913474 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00866669 |
| 97 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99825125 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99643968 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98782354 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98777115 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97632963 |
| 102 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97540922 |
| 103 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97238282 |
| 104 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.97211776 |
| 105 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97113859 |
| 106 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97080207 |
| 107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96795446 |
| 108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96330325 |
| 109 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95337654 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94602409 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94412371 |
| 112 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94286173 |
| 113 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94082807 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93580184 |
| 115 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93372909 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92776853 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92679484 |
| 118 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92554988 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92396122 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92148601 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92053975 |
| 122 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91959028 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91881140 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91662860 |
| 125 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90704396 |
| 126 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90704396 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90562275 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88605037 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88344616 |
| 130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88250127 |
| 131 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88186927 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88000061 |
| 133 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87769653 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87506745 |
| 135 | AR_19668381_ChIP-Seq_PC3_Human | 0.87503918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.48686010 |
| 2 | MP0003136_yellow_coat_color | 6.02430589 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 4.47472378 |
| 4 | MP0000372_irregular_coat_pigmentation | 4.03582063 |
| 5 | MP0005551_abnormal_eye_electrophysiolog | 3.31702671 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.30305240 |
| 7 | MP0005171_absent_coat_pigmentation | 3.11495909 |
| 8 | MP0002090_abnormal_vision | 2.99452050 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.77065676 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.73104154 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.59075855 |
| 12 | MP0000371_diluted_coat_color | 2.42583412 |
| 13 | MP0003011_delayed_dark_adaptation | 2.35601090 |
| 14 | MP0001324_abnormal_eye_pigmentation | 2.34347758 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.26416157 |
| 16 | MP0003045_fibrosis | 2.25824836 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.24545151 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.23967299 |
| 19 | MP0005409_darkened_coat_color | 2.16610962 |
| 20 | MP0000015_abnormal_ear_pigmentation | 1.82087299 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.81192739 |
| 22 | MP0005253_abnormal_eye_physiology | 1.77421410 |
| 23 | MP0005408_hypopigmentation | 1.75085193 |
| 24 | MP0008004_abnormal_stomach_pH | 1.69004081 |
| 25 | MP0005275_abnormal_skin_tensile | 1.64581118 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.59650589 |
| 27 | MP0004858_abnormal_nervous_system | 1.56207044 |
| 28 | MP0003091_abnormal_cell_migration | 1.55800367 |
| 29 | MP0001958_emphysema | 1.54619931 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.54045943 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.53395558 |
| 32 | MP0004510_myositis | 1.47361230 |
| 33 | MP0005197_abnormal_uvea_morphology | 1.46720166 |
| 34 | MP0002254_reproductive_system_inflammat | 1.41705545 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.39582713 |
| 36 | MP0003252_abnormal_bile_duct | 1.35789513 |
| 37 | MP0000751_myopathy | 1.34906445 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.30737474 |
| 39 | MP0009046_muscle_twitch | 1.30688297 |
| 40 | MP0004233_abnormal_muscle_weight | 1.28965220 |
| 41 | MP0002938_white_spotting | 1.27543079 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.26511488 |
| 43 | MP0003879_abnormal_hair_cell | 1.22602824 |
| 44 | MP0003279_aneurysm | 1.20810299 |
| 45 | MP0000604_amyloidosis | 1.18999595 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.17874206 |
| 47 | MP0001299_abnormal_eye_distance/ | 1.16307599 |
| 48 | MP0005195_abnormal_posterior_eye | 1.15018743 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.11544158 |
| 50 | MP0005360_urolithiasis | 1.08343690 |
| 51 | MP0000749_muscle_degeneration | 1.04774809 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.03371368 |
| 53 | MP0003436_decreased_susceptibility_to | 1.03314801 |
| 54 | MP0002229_neurodegeneration | 1.02242426 |
| 55 | MP0002928_abnormal_bile_duct | 1.02193205 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.01368414 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.00671739 |
| 58 | MP0002998_abnormal_bone_remodeling | 0.99734987 |
| 59 | MP0005377_hearing/vestibular/ear_phenot | 0.97483167 |
| 60 | MP0003878_abnormal_ear_physiology | 0.97483167 |
| 61 | MP0002168_other_aberrant_phenotype | 0.97309078 |
| 62 | MP0002332_abnormal_exercise_endurance | 0.96417337 |
| 63 | MP0004947_skin_inflammation | 0.96322223 |
| 64 | MP0005623_abnormal_meninges_morphology | 0.95757731 |
| 65 | MP0002972_abnormal_cardiac_muscle | 0.92772597 |
| 66 | MP0004215_abnormal_myocardial_fiber | 0.91394932 |
| 67 | MP0005023_abnormal_wound_healing | 0.91392612 |
| 68 | MP0005410_abnormal_fertilization | 0.89406730 |
| 69 | MP0002075_abnormal_coat/hair_pigmentati | 0.89388095 |
| 70 | MP0003303_peritoneal_inflammation | 0.88645641 |
| 71 | MP0001968_abnormal_touch/_nociception | 0.87116082 |
| 72 | MP0001533_abnormal_skeleton_physiology | 0.85964622 |
| 73 | MP0004381_abnormal_hair_follicle | 0.81698531 |
| 74 | MP0002419_abnormal_innate_immunity | 0.80735993 |
| 75 | MP0004130_abnormal_muscle_cell | 0.79093113 |
| 76 | MP0002177_abnormal_outer_ear | 0.75986414 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.74946642 |
| 78 | MP0000538_abnormal_urinary_bladder | 0.74005914 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.73001518 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.72835720 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.72790614 |
| 82 | MP0004270_analgesia | 0.71697071 |
| 83 | MP0009840_abnormal_foam_cell | 0.71526279 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 0.70401053 |
| 85 | MP0000733_abnormal_muscle_development | 0.69275458 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.68825824 |
| 87 | MP0001984_abnormal_olfaction | 0.68592001 |
| 88 | MP0003646_muscle_fatigue | 0.67455344 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.67401580 |
| 90 | MP0004043_abnormal_pH_regulation | 0.66834511 |
| 91 | MP0004087_abnormal_muscle_fiber | 0.66141946 |
| 92 | MP0000427_abnormal_hair_cycle | 0.64771164 |
| 93 | MP0010307_abnormal_tumor_latency | 0.64319721 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.64216153 |
| 95 | MP0001186_pigmentation_phenotype | 0.60933901 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.60394950 |
| 97 | MP0009697_abnormal_copulation | 0.60256822 |
| 98 | MP0004484_altered_response_of | 0.60224384 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.59722990 |
| 100 | MP0005620_abnormal_muscle_contractility | 0.59672030 |
| 101 | MP0002060_abnormal_skin_morphology | 0.58485293 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.57729817 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.56159881 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.55092363 |
| 105 | MP0009764_decreased_sensitivity_to | 0.54621606 |
| 106 | MP0003448_altered_tumor_morphology | 0.54517515 |
| 107 | MP0003634_abnormal_glial_cell | 0.53820610 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.53688095 |
| 109 | MP0003828_pulmonary_edema | 0.53212806 |
| 110 | MP0000367_abnormal_coat/_hair | 0.52885105 |
| 111 | MP0002796_impaired_skin_barrier | 0.51917332 |
| 112 | MP0000920_abnormal_myelination | 0.49954402 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.48468773 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.44732038 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.44519800 |
| 116 | MP0006054_spinal_hemorrhage | 0.41253838 |
| 117 | MP0003632_abnormal_nervous_system | 0.40570139 |
| 118 | MP0000377_abnormal_hair_follicle | 0.39716705 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.39555709 |
| 120 | MP0003718_maternal_effect | 0.38262938 |
| 121 | MP0002102_abnormal_ear_morphology | 0.38048327 |
| 122 | MP0005165_increased_susceptibility_to | 0.37883910 |
| 123 | MP0005395_other_phenotype | 0.33843677 |
| 124 | MP0005164_abnormal_response_to | 0.32829153 |
| 125 | MP0004885_abnormal_endolymph | 0.32697664 |
| 126 | MP0005451_abnormal_body_composition | 0.32387807 |
| 127 | MP0003195_calcinosis | 0.30290819 |
| 128 | MP0001851_eye_inflammation | 0.27099623 |
| 129 | MP0006082_CNS_inflammation | 0.26533651 |
| 130 | MP0004272_abnormal_basement_membrane | 0.25098319 |
| 131 | MP0003329_amyloid_beta_deposits | 0.24148024 |
| 132 | MP0000627_abnormal_mammary_gland | 0.23991404 |
| 133 | MP0003795_abnormal_bone_structure | 0.23243183 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.22981669 |
| 135 | MP0001664_abnormal_digestion | 0.22377350 |
| 136 | MP0001756_abnormal_urination | 0.21823545 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.21354959 |
| 138 | MP0005193_abnormal_anterior_eye | 0.20859955 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.20843220 |
| 140 | MP0006138_congestive_heart_failure | 0.20296215 |
| 141 | MP0008569_lethality_at_weaning | 0.19595436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.75631298 |
| 2 | White forelock (HP:0002211) | 7.53680572 |
| 3 | Patchy hypopigmentation of hair (HP:0011365) | 6.79942198 |
| 4 | Hypopigmentation of the fundus (HP:0007894) | 5.42665514 |
| 5 | Generalized hypopigmentation of hair (HP:0011358) | 4.57362592 |
| 6 | Hypoplasia of the iris (HP:0007676) | 4.00989600 |
| 7 | Central scotoma (HP:0000603) | 3.95712701 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 3.95109548 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.94550555 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.94550555 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.94550555 |
| 12 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.91941482 |
| 13 | Heterochromia iridis (HP:0001100) | 3.74631262 |
| 14 | Abnormal auditory evoked potentials (HP:0006958) | 3.73018759 |
| 15 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.66231882 |
| 16 | Dyschromatopsia (HP:0007641) | 3.56009280 |
| 17 | Congenital sensorineural hearing impairment (HP:0008527) | 3.50568891 |
| 18 | Premature graying of hair (HP:0002216) | 3.44136644 |
| 19 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.29034458 |
| 20 | Freckling (HP:0001480) | 3.26336778 |
| 21 | Pigmentary retinal degeneration (HP:0001146) | 3.13931936 |
| 22 | Hypoplastic ischia (HP:0003175) | 3.09133140 |
| 23 | Generalized hypopigmentation (HP:0007513) | 2.95633365 |
| 24 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.94262929 |
| 25 | Hypoplasia of the fovea (HP:0007750) | 2.94262929 |
| 26 | Decreased central vision (HP:0007663) | 2.92449386 |
| 27 | Abnormality of the ischium (HP:0003174) | 2.90944504 |
| 28 | Scotoma (HP:0000575) | 2.86010658 |
| 29 | Hydroxyprolinuria (HP:0003080) | 2.75972501 |
| 30 | Abnormality of proline metabolism (HP:0010907) | 2.75972501 |
| 31 | Submucous cleft hard palate (HP:0000176) | 2.75229243 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.75174454 |
| 33 | Febrile seizures (HP:0002373) | 2.70481348 |
| 34 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.66498558 |
| 35 | Ocular albinism (HP:0001107) | 2.59953372 |
| 36 | Thick nail (HP:0001805) | 2.58178776 |
| 37 | Axonal loss (HP:0003447) | 2.57608439 |
| 38 | Blue irides (HP:0000635) | 2.49594207 |
| 39 | Aortic aneurysm (HP:0004942) | 2.49265796 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45597419 |
| 41 | Cone-rod dystrophy (HP:0000548) | 2.41785951 |
| 42 | Premature rupture of membranes (HP:0001788) | 2.39114918 |
| 43 | Long toe (HP:0010511) | 2.38809031 |
| 44 | Chorioretinal atrophy (HP:0000533) | 2.37528632 |
| 45 | Absent frontal sinuses (HP:0002688) | 2.36507996 |
| 46 | Abnormality of the fovea (HP:0000493) | 2.36050816 |
| 47 | Cutaneous melanoma (HP:0012056) | 2.33736146 |
| 48 | Progressive visual loss (HP:0000529) | 2.33005829 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.32368808 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.29642042 |
| 51 | Vitreoretinal degeneration (HP:0000655) | 2.28852031 |
| 52 | Right ventricular cardiomyopathy (HP:0011663) | 2.26087457 |
| 53 | Increased corneal curvature (HP:0100692) | 2.24469196 |
| 54 | Keratoconus (HP:0000563) | 2.24469196 |
| 55 | Loss of speech (HP:0002371) | 2.24164076 |
| 56 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.23971831 |
| 57 | Macular degeneration (HP:0000608) | 2.23860947 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.23424089 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.22065549 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20107558 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20107558 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20107558 |
| 63 | Vascular tortuosity (HP:0004948) | 2.18692717 |
| 64 | Iris hypopigmentation (HP:0007730) | 2.18608011 |
| 65 | Choroideremia (HP:0001139) | 2.15817102 |
| 66 | Urethral obstruction (HP:0000796) | 2.15542041 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.15419315 |
| 68 | Gingivitis (HP:0000230) | 2.12637035 |
| 69 | Severe visual impairment (HP:0001141) | 2.12170755 |
| 70 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12017841 |
| 71 | Cupped ribs (HP:0000887) | 2.11923850 |
| 72 | Flat acetabular roof (HP:0003180) | 2.10962284 |
| 73 | Increased connective tissue (HP:0009025) | 2.08948052 |
| 74 | Prolonged QT interval (HP:0001657) | 2.08137207 |
| 75 | Arterial tortuosity (HP:0005116) | 2.08112652 |
| 76 | Hand muscle atrophy (HP:0009130) | 2.07845354 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.07691804 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.07691804 |
| 79 | Underdeveloped nasal alae (HP:0000430) | 2.05848536 |
| 80 | Protuberant abdomen (HP:0001538) | 2.05348447 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.04481986 |
| 82 | Hyporeflexia of lower limbs (HP:0002600) | 2.03675595 |
| 83 | Peripheral hypomyelination (HP:0007182) | 2.00971797 |
| 84 | Atrophic scars (HP:0001075) | 1.99875582 |
| 85 | Lip pit (HP:0100267) | 1.97839858 |
| 86 | Prostate neoplasm (HP:0100787) | 1.97558650 |
| 87 | Hyperkalemia (HP:0002153) | 1.97259143 |
| 88 | Photophobia (HP:0000613) | 1.97082102 |
| 89 | Distal upper limb amyotrophy (HP:0007149) | 1.96625056 |
| 90 | Upper limb amyotrophy (HP:0009129) | 1.96625056 |
| 91 | Genetic anticipation (HP:0003743) | 1.96104978 |
| 92 | Dysostosis multiplex (HP:0000943) | 1.95926630 |
| 93 | Mucopolysacchariduria (HP:0008155) | 1.95054492 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95054492 |
| 95 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.94070717 |
| 96 | Ulnar claw (HP:0001178) | 1.93527122 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.93081315 |
| 98 | Albinism (HP:0001022) | 1.93031073 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92190719 |
| 100 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.91781672 |
| 101 | Synophrys (HP:0000664) | 1.91355948 |
| 102 | Syncope (HP:0001279) | 1.91040235 |
| 103 | Eczematoid dermatitis (HP:0000976) | 1.91006571 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.88739036 |
| 105 | Abnormality of vision evoked potentials (HP:0000649) | 1.88636225 |
| 106 | Epiphyseal dysplasia (HP:0002656) | 1.87852179 |
| 107 | Spinal muscular atrophy (HP:0007269) | 1.87709271 |
| 108 | Retinal atrophy (HP:0001105) | 1.86639222 |
| 109 | Lower limb amyotrophy (HP:0007210) | 1.85361393 |
| 110 | Aortic dissection (HP:0002647) | 1.84407313 |
| 111 | Progressive cerebellar ataxia (HP:0002073) | 1.83854756 |
| 112 | Abolished electroretinogram (ERG) (HP:0000550) | 1.83265169 |
| 113 | Mitral stenosis (HP:0001718) | 1.81124450 |
| 114 | Epileptic encephalopathy (HP:0200134) | 1.80430422 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.77651288 |
| 116 | Frequent falls (HP:0002359) | 1.77342503 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76347985 |
| 118 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75947204 |
| 119 | Asymmetric septal hypertrophy (HP:0001670) | 1.75938474 |
| 120 | Cervical subluxation (HP:0003308) | 1.75762627 |
| 121 | Absence seizures (HP:0002121) | 1.74222952 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.74041947 |
| 123 | Atrial fibrillation (HP:0005110) | 1.73074408 |
| 124 | Progressive sensorineural hearing impairment (HP:0000408) | 1.71562580 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.70332675 |
| 126 | Severe Myopia (HP:0011003) | 1.70282157 |
| 127 | Ovoid vertebral bodies (HP:0003300) | 1.70109363 |
| 128 | Myocardial infarction (HP:0001658) | 1.70090125 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 1.69353603 |
| 130 | Akinesia (HP:0002304) | 1.69233113 |
| 131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69146332 |
| 132 | Deformed sella turcica (HP:0002681) | 1.58316601 |
| 133 | Abnormal glucose tolerance (HP:0001952) | 1.57904570 |
| 134 | Protrusio acetabuli (HP:0003179) | 1.57899269 |
| 135 | Neonatal short-limb short stature (HP:0008921) | 1.56126145 |
| 136 | Glucose intolerance (HP:0000833) | 1.52043786 |
| 137 | Decreased motor nerve conduction velocity (HP:0003431) | 1.49442228 |
| 138 | Paraparesis (HP:0002385) | 1.49343187 |
| 139 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.49328732 |
| 140 | Spastic paraparesis (HP:0002313) | 1.47469711 |
| 141 | Spondylolisthesis (HP:0003302) | 1.46505369 |
| 142 | Femoral bowing (HP:0002980) | 1.46312911 |
| 143 | Germ cell neoplasia (HP:0100728) | 1.45002333 |
| 144 | Interstitial pulmonary disease (HP:0006530) | 1.42413118 |
| 145 | Absent/shortened dynein arms (HP:0200106) | 1.42042980 |
| 146 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.42042980 |
| 147 | Upper limb muscle weakness (HP:0003484) | 1.41633373 |
| 148 | Rhinitis (HP:0012384) | 1.38042774 |
| 149 | Action tremor (HP:0002345) | 1.37524715 |
| 150 | Subacute progressive viral hepatitis (HP:0006572) | 1.36872979 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.36519951 |
| 152 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.36412930 |
| 153 | Wormian bones (HP:0002645) | 1.35867067 |
| 154 | Abnormal ciliary motility (HP:0012262) | 1.34149480 |
| 155 | Cranial hyperostosis (HP:0004437) | 1.31535722 |
| 156 | Diminished movement (HP:0002374) | 1.30084824 |
| 157 | Abnormality of the sella turcica (HP:0002679) | 1.29800604 |
| 158 | Decreased circulating renin level (HP:0003351) | 1.29714258 |
| 159 | Global brain atrophy (HP:0002283) | 1.29546202 |
| 160 | Infertility (HP:0000789) | 1.29042448 |
| 161 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.28891977 |
| 162 | Tubulointerstitial nephritis (HP:0001970) | 1.27641078 |
| 163 | Hypokinesia (HP:0002375) | 1.26961665 |
| 164 | Large for gestational age (HP:0001520) | 1.25369677 |
| 165 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.24269855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.46482024 |
| 2 | WEE1 | 3.65865466 |
| 3 | TTN | 2.77020576 |
| 4 | EPHA3 | 2.61079099 |
| 5 | DDR2 | 2.54629767 |
| 6 | LMTK2 | 2.13852614 |
| 7 | CAMK1D | 2.05234513 |
| 8 | RIPK1 | 2.03988738 |
| 9 | FRK | 2.03472004 |
| 10 | CAMK1G | 1.95467487 |
| 11 | RIPK4 | 1.94154179 |
| 12 | MET | 1.90642626 |
| 13 | ACVR1B | 1.89594231 |
| 14 | MAP3K14 | 1.79395573 |
| 15 | STK38 | 1.71179878 |
| 16 | ICK | 1.67227067 |
| 17 | ERBB4 | 1.65762006 |
| 18 | LATS1 | 1.65715498 |
| 19 | MAP3K13 | 1.65006744 |
| 20 | NTRK1 | 1.63069119 |
| 21 | JAK1 | 1.61960727 |
| 22 | TAOK3 | 1.57027710 |
| 23 | MAPKAPK3 | 1.54374656 |
| 24 | NEK6 | 1.53989409 |
| 25 | TRPM7 | 1.42450196 |
| 26 | FER | 1.38436082 |
| 27 | PIK3CA | 1.37822486 |
| 28 | PAK4 | 1.37735324 |
| 29 | TYK2 | 1.37573392 |
| 30 | MARK3 | 1.34549872 |
| 31 | WNK1 | 1.28011799 |
| 32 | BMX | 1.26185571 |
| 33 | DMPK | 1.22583650 |
| 34 | PAK6 | 1.22336197 |
| 35 | TBK1 | 1.19565995 |
| 36 | KSR2 | 1.19447281 |
| 37 | PDPK1 | 1.18300341 |
| 38 | INSRR | 1.18129899 |
| 39 | GSK3A | 1.17875264 |
| 40 | NEK9 | 1.14433760 |
| 41 | MAP3K2 | 1.14317673 |
| 42 | DAPK2 | 1.14297113 |
| 43 | MAP3K9 | 1.13672999 |
| 44 | NUAK1 | 1.08474034 |
| 45 | ZAP70 | 1.07204779 |
| 46 | CDK12 | 1.06839457 |
| 47 | CAMKK1 | 1.06702351 |
| 48 | AKT3 | 1.03947582 |
| 49 | BMPR2 | 1.02280374 |
| 50 | SGK3 | 0.99559788 |
| 51 | PLK2 | 0.96769198 |
| 52 | NEK1 | 0.95151819 |
| 53 | PTK2 | 0.95016842 |
| 54 | SGK2 | 0.94677165 |
| 55 | PHKG2 | 0.91886873 |
| 56 | PHKG1 | 0.91886873 |
| 57 | CAMKK2 | 0.90391361 |
| 58 | SIK2 | 0.88839470 |
| 59 | PAK3 | 0.88363302 |
| 60 | PTK6 | 0.86495058 |
| 61 | PRKAA2 | 0.86322379 |
| 62 | MUSK | 0.85768848 |
| 63 | MELK | 0.85351325 |
| 64 | PTK2B | 0.84603700 |
| 65 | PRKG2 | 0.84522103 |
| 66 | RET | 0.81641211 |
| 67 | PDK2 | 0.81518429 |
| 68 | WNK4 | 0.81280420 |
| 69 | TYRO3 | 0.80264881 |
| 70 | STK38L | 0.79062100 |
| 71 | CSNK1A1L | 0.78107583 |
| 72 | GRK7 | 0.77354235 |
| 73 | PRKCH | 0.77029033 |
| 74 | ERBB2 | 0.75396651 |
| 75 | MYLK | 0.74459778 |
| 76 | PRKD3 | 0.74244234 |
| 77 | MAP3K4 | 0.72774653 |
| 78 | SIK1 | 0.72657170 |
| 79 | STK3 | 0.72552259 |
| 80 | TESK1 | 0.72501520 |
| 81 | FGFR3 | 0.71883493 |
| 82 | PRKCE | 0.71436792 |
| 83 | LATS2 | 0.71037925 |
| 84 | PRKD1 | 0.70319825 |
| 85 | SGK1 | 0.70292096 |
| 86 | ABL2 | 0.69719977 |
| 87 | MOS | 0.69686772 |
| 88 | PRKAA1 | 0.69613342 |
| 89 | CDK7 | 0.69181109 |
| 90 | ERN1 | 0.66921802 |
| 91 | KIT | 0.66467735 |
| 92 | IRAK3 | 0.66442127 |
| 93 | MAPK11 | 0.64792590 |
| 94 | TRIB3 | 0.63822435 |
| 95 | PNCK | 0.63175867 |
| 96 | PKN2 | 0.62391113 |
| 97 | SGK494 | 0.60580873 |
| 98 | SGK223 | 0.60580873 |
| 99 | IKBKE | 0.60476572 |
| 100 | PRKD2 | 0.60347933 |
| 101 | BMPR1B | 0.59267398 |
| 102 | FGFR2 | 0.58841148 |
| 103 | MAP3K7 | 0.57989097 |
| 104 | CAMK2D | 0.57900387 |
| 105 | RPS6KA2 | 0.56656591 |
| 106 | EPHB1 | 0.55582520 |
| 107 | GRK1 | 0.54902725 |
| 108 | PBK | 0.54635263 |
| 109 | CHUK | 0.54369371 |
| 110 | SCYL2 | 0.54325385 |
| 111 | CDK3 | 0.53998745 |
| 112 | JAK3 | 0.53911424 |
| 113 | ROCK1 | 0.53862032 |
| 114 | MTOR | 0.53854201 |
| 115 | MINK1 | 0.53092501 |
| 116 | MAP3K5 | 0.52864546 |
| 117 | CDC42BPA | 0.52268323 |
| 118 | MAP2K1 | 0.51087209 |
| 119 | PDGFRB | 0.51071220 |
| 120 | CDK6 | 0.50981002 |
| 121 | MATK | 0.50349133 |
| 122 | EGFR | 0.49139784 |
| 123 | MAP3K1 | 0.48737467 |
| 124 | ADRBK1 | 0.48634269 |
| 125 | SRC | 0.48374888 |
| 126 | HCK | 0.48136706 |
| 127 | PDGFRA | 0.47444797 |
| 128 | PIK3CG | 0.47363918 |
| 129 | CSNK1G2 | 0.45731129 |
| 130 | YES1 | 0.45535936 |
| 131 | PDK1 | 0.44654452 |
| 132 | GRK5 | 0.44423116 |
| 133 | TGFBR2 | 0.44240947 |
| 134 | MAPK15 | 0.43967967 |
| 135 | MAPK7 | 0.43711414 |
| 136 | FYN | 0.42345546 |
| 137 | MAP3K3 | 0.41417135 |
| 138 | IKBKB | 0.40022881 |
| 139 | JAK2 | 0.39790942 |
| 140 | AKT2 | 0.39548835 |
| 141 | STK39 | 0.34714845 |
| 142 | CSNK1G1 | 0.34541829 |
| 143 | PAK2 | 0.33381431 |
| 144 | FGFR1 | 0.33362473 |
| 145 | CSNK1G3 | 0.32009945 |
| 146 | MAPK1 | 0.31547304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.79813851 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04792640 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 1.78066872 |
| 4 | Melanogenesis_Homo sapiens_hsa04916 | 1.69909384 |
| 5 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.64322459 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.62917589 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62700067 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60051376 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.50014349 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47701421 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45717708 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45657231 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45218445 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.43300369 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.41088664 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35519446 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.27201882 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.23366839 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22084479 |
| 20 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20795627 |
| 21 | Prostate cancer_Homo sapiens_hsa05215 | 1.18594809 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17534796 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.15115336 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14671219 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14135529 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12546896 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08944956 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08574436 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.08509383 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06318447 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02684000 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02216698 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01829304 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99951026 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97298529 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 0.97225773 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97125413 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 0.96628096 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 0.94526146 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 0.91844046 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 0.90866021 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90789190 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.90184496 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.88232288 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88180822 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88001735 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.87878401 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86781042 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86378791 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85932180 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85606602 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85230633 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85049853 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84649368 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83351654 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83003925 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82562203 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82321543 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80918961 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78543222 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78145433 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77259759 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77037641 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.76965541 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.76955655 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.76894777 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76693717 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76534229 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76139859 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75744060 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75409645 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75339321 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74794643 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.74788583 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74387588 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74367501 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74339061 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74161240 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.73152839 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72601321 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.72578594 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71855275 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71389579 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70749382 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70575797 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70524433 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70279037 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.69577008 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.69503709 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69397944 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68533090 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67476247 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67461109 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.66524693 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66031501 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.65375461 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64320356 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64073826 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63828922 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63713549 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62726017 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62058532 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61570141 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61026182 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.60258537 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59563295 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59553924 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59520805 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58074209 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.56749597 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.55992670 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55880939 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55779462 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55288368 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55026094 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54864313 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.54673836 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51984859 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51799763 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51737783 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50690037 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50407217 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50089928 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49823776 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49323166 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49003066 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.48524994 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48077295 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47731754 |
| 130 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47730079 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47181036 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46461390 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46133664 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.45694457 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45156964 |

